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Abstract
One of the main directions of improving medical care was the introduction of inpatient forms of medical care for patients who 
do not require round-the-clock supervision. 
Aim of the research: to prove the effectiveness and economic feasibility of minimally invasive procedures in outpatient conditions. 
Materials and methods. The study included 3524 patients in the period from 2010 to 2017, who underwent transrectal pros-
tate biopsy on the basis of the Department of urology of polyclinic No. 195 of the Western district of Moscow. For comparison, the 
patients were taken, who underwent a biopsy of the prostate gland at the base hospital No. 31, No. 51, No. 17.
Results. The average number of biopsies performed in hospital No. 31, No. 51 and No. 17 for the year amounted to 
344 biopsies, and the average detectability of prostate cancer was 142 (41.3 %). The average number of biopsies per year in the 
urology department of the branch number 2 GP No. 195 amounted to 440.5, and the average detectability of prostate cancer – 
152.8 (34.7 %). Thus, with comparable inpatient detection of prostate cancer in one large outpatient urology center, an average of 
28 % more biopsies are performed (440.5 versus 344) than in 3 hospitals over a comparable period of time.
Conclusions. Inpatient technologies can reduce the burden on hospitals. The development of hospital-replacing forms is 
determined by the need of the population and for efficient use of financial and technical resources of health care.
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Order of the Government of the Russian Federation No. 2511-p dated December 24, 2012 
approved the “Concept of Healthcare Development of the Russian Federation” suggesting the in-
troduction of new and development of existing technologies used outside the hospital, which will 
allow not only to carry out highly effective diagnostics and treatment, but also to effectively spend 
financial resources. Today, much of the traditional inpatient surgical care and invasive manipu-
lations are moved to the outpatient unit. The most effective, proven and internationally recog-
nized, in accordance with the federal law “On Strategic Planning in the Russian Federation”, are 
health-saving technologies based on conducting mass-directed health screenings as part of clinical 
examinations and preventive examinations on an outpatient basis [1, 2]. These include one of the 
most important oncological tasks – early diagnosis of prostate cancer.
Prostate gland is the male sexual gland which is present in front of the rectum and between 
the bladder and penis [3]. Prostate cancer (prostate cancer) is one of the most important medical 
problems concerning the male population. Age is the major risk factor but there is also an increased 
risk in those with a family history of either prostatic or breast cancer [4]. Incidence and mortality 
rates for prostate cancer are highly variable worldwide [5, 6].
In terms of prevalence in Europe (>200 cases of morbidity per 100,000 population), this 
malignancy exceeds the incidence of lung cancer and colorectal cancer [7, 8]. In addition, cur-
rently in the structure of cancer incidence of prostate cancer is in second place after lung cancer 
and in third place in the structure of mortality [7, 9]. In Russia, the incidence of prostate cancer is 
steadily increasing: over the past 1.5 decades, it has increased almost 2 times; only 2010 registered 
107 942 patients [10]. In 2012, 28,560 new cases of prostate cancer were reported in Russia, with a 
morbidity rate of 40.1 per 100,000 males [11].
It is 2 to 3 times more in person whose brother or father has prostate cancer as compared 
to those who have no family history of prostate cancer. If a person has three immediate family 
members suffering from prostate cancer then there is 10 times more chance of prostate cancer as 
compared to person that has no family history of prostate cancer. High fat diet also increases the 
chance of prostate cancer [12, 13].
Patients may be asymptomatic but the commonest complaint is difficulty with micturition, 
straining to start, frequency, and nocturia. All these can arise from benign prostatic hypertrophy as 
well as malignancy. Obstructive voiding symptoms are most often due to benign prostatic hyper-
plasia which occurs in the same age group. Malignant changes occur in prostate cells that further 
proceed toward carcinoma. Environmental and genetic influences cause promotional proceedings 
and sequence of commencement.
Prostate specific antigen increases in enlarged prostate gland, older age, prostatitis, ejacu-
lation, riding a bicycle, certain urologic conditions and certain medications [14]. Prostate specific 
antigen decreases in 5-alpha reductase inhibitors, herbal mixtures, obesity, aspirin use, thiazide 
diuretic, statin. Patients with intermediate levels of PSA usually have localized and therefore po-
tentially curable cancers.
The widespread use of prophylactic studies of men to identify prostate cancer by deter-
mining the level of prostate-specific antigen (PSA) led to a significant increase in the number of 
prostate gland biopsies (PG), a method currently recognized as the “gold standard” for diagnosing 
prostate cancer.
PG biopsy provides the physician with the necessary information on the presence of altered 
prostate tissue, namely: high and low prostate intraepithelial neoplasia (PIN), atypical small acinar 
hyperplasia or prostate cancer, tumor localization, its length in the biopsy, the presence of perineu-
ral, perivasal invasion, the stage of differentiation of tumor cells (gradation on the Gleason scale) 
[15, 16]. Biopsy is the final stage of primary diagnosis of prostate cancer and the basis for starting 
timely adequate treatment, which is especially important in the conditions of increasing the prev-
alence of this disease [17].
Thus, given the steady increase in the incidence of prostate cancer, it is not surprising that 








2. Aim of research 
To prove the effectiveness and economic feasibility of minimally invasive procedures in 
outpatient conditions. 
3. Materials and methods
On the basis of the urology department of branch No. 2 of the state budgetary institution of 
health care GP No. 195 of the Western Administrative District of Moscow, a service for conducting 
a number of minimally invasive diagnostic and surgical interventions has been successfully oper-
ating for more than 7 years. The centralized coordination of the work of doctors of different levels 
within the administrative district allows not deviating from the implemented standard methods of 
invasive manipulations and patient management algorithms.
In the period from 2010 to 2017, the urology department on the basis of the branch No. 2 of 
the city polyclinic No. 195 of the Western District of Moscow was sent for further examination in 
connection with suspected PCa 3524 patients, aged 50 to 78 years (mean age 62 years). A standard 
examination of patients before a biopsy was to conduct a physical examination, including a digi-
tal rectal examination, measurement of PSA, transrectal ultrasound of the RV. Patients with PSA 
values greater than 4 ng/ml were given a transrectal multifocal biopsy of the prostate according to 
the standard procedure of 12 points. Given the outpatient nature of the manipulation, all patients 
received appropriate training. Preoperative standard examination included clinical, biochemical 
blood and urine tests, examination of the coagulation system, blood group and Rh factor, necessary 
tests for the detection of infectious diseases, an electrocardiogram. The patient underwent a man-
datory examination by a therapist, and when clinically significant pathologies were identified, they 
were treated before a prostate biopsy.
A cleansing enema was performed on the night before and on the morning of the ma-
nipulation. Antibacterial prophylaxis was usually performed with fluoroquinolone preparations 
(ciprofloxacin and levofloxacin) a day before the manipulation and continued for 3 days after a 
prostate biopsy.
4. Results
According to the results of histological studies of biopsy material, 3524 patients of the urol-
ogy department of branch No. 2 of the GP No. 195, prostate cancer were detected in 1224 patients, 
thus the detectability of prostate cancer was 34.7 %.
When discussing the feasibility and effectiveness of inpatient technologies, it is first of all nec-
essary to compare statistical data obtained in outpatient settings with the inpatient hospital indicators 
of the respective urban district. In the city hospitals of the Western Administrative District, namely, in 
the urology departments of GKB No. 31, GKB No. 51 and GKB No. 17 in 2010, a total of 313 prostate 
biopsies were performed, in 2011 – 230 biopsies, for 2012 – 239 biopsies, for 2013 – 295 biopsies, for 
2014 – 324 biopsies, for 2015 – 342 biopsies, in 2016 – 292 biopsies, in 2017 – 716 biopsies. 
The detectability of prostate cancer for the given years according to the hospitals was 128 
(41 %), 129 (56 %), 96 (40 %), 105 (35.6 %), 180 (55 %), 138 (40.3 %), 142 (48.6 %), 218 (30.5 %) 
cases of newly diagnosed PCa, respectively. Thus, from 2010 to 2017, 2751 prostate biopsies were 
performed in city hospitals, and in 1136 men, prostate cancer was verified. 
The average number of biopsies performed in all hospitals of the Western Administrative 
District of Moscow for the year amounted to 344 biopsies, and the average detectability of prostate 
cancer was 142 (41.3 %). 
In the urology department of the branch number 2 of the city polyclinic No. 195 in 2010, 
236 prostate biopsies were performed, in 2011 – 319 biopsies, for 2012 – 566 biopsies, for 2013 – 
448 biopsies, for 2014 – 554 biopsies, for 2015 – 663 biopsies, in 2016 – 366 biopsies, in 2017 – 
372 biopsies. The detectability of prostate cancer for the given years in this department was 
99 (41.9 %), 107 (33.5 %), 197 (34.8 %), 161 (36 %), 204 (36.6 %), 208 (31.3 %), 122 (33 %), 
125 (33.6 %) cases, respectively. Thus, for the period from 2010 to 2017 inclusive, the average num-
ber of completed biopsies per year in the urology department of the branch number 2 GP number 
195 amounted to 440.5, and the average detectability of prostate cancer – 152.8 (34.7 %) (Table 1).
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The number of prostate biopsies and frequency of prostate cancer detection for the period 2010–2017
Year
GKB No. 31, 51 ,17 Polyclinic No. 195, branch No. 2
Prostate biopsies Prostate cancer Prostate biopsies Prostate cancer
2010 313 128 (41 %) 236 99 (41.9 %)
2011 230 129 (56 %) 319 107 (33.5 %)
2012 239 96 (40 %) 566 197 (34.8 %)
2013 295 105 (35.6 %) 448 161 (36 %)
2014 324 180 (55 %) 554 204 (36.6 %)
2015 342 138 (40.3 %) 663 208 (31.3 %)
2016 292 142 (48.6 %) 366 122 (33 %)
2017 716 218 (30.5 %) 372 125 (33.6 %)
Total 2751 1136 (41.3 %) 3524 1224 (34.7 %)
From the above data, it follows that with comparable inpatient detection of prostate cancer in 
one large outpatient urology center, an average of 28 % more biopsies are performed (440.5 versus 344) 
than in three hospitals over a comparable period of time.
With a similar ratio of indicators, inpatient technologies, at first glance, fully justified their 
existence and confirmed their high efficiency, but the question remains of stopping acute conditions 
in outpatient conditions when performing invasive procedures and complications that develop after 
their implementation. It is fair to say that hospitals in this situation have more opportunities to man-
age patients with urgent conditions. Considering an example of a prostate biopsy, the three most 
common complications should be highlighted: acute urinary retention, rectal bleeding, and acute 
inflammatory diseases of the genitourinary system. Several factors were called upon to neutralize 
these conditions: firstly, the specific prevention of these complications is carried out; secondly, the 
postoperative management of patients according to generally accepted algorithms that allow clin-
ically insignificant rectal bleeding to stop in a short time. Separately, it should be noted that there 
is continuity between the outpatient unit and the stations in Moscow. This connection is regulated 
and supported by the main specialists of the city. Given the presence of one of the fundamental 
factors, the outpatient city center has the ability to urgently refer the patient to the hospital in case 
of an emergency.
In the urology department of the branch number 2 GP number 195 for the period 2010– 
2017 prostate biopsy in 20 (1 %) patients was complicated by rectal hemorrhage, in 17 (0.8 %) 
patients in the immediate postoperative period developed acute orchiepididymitis, in one patient 
(0.04 %) – acute urinary retention, in three patients (0.14 %) there was a brief loss of consciousness 
during the manipulation. Some patients with non-invasion of an acute condition were urgently hos-
pitalized in hospitals of the Western Administrative District of Moscow.
5. Discussion
In summary, it should be noted that the results of a number of studies, as well as our study, 
stationary technology in the short years of its existence and deservedly included in the practice 
of the routine of the centers [19, 20]. Work in this direction is going on, maybe not as quickly as 
we would like, but it is already bearing fruit in the form of saving financial resources of domestic 
health care by redirecting the flow of certain invasive procedures and small surgical interventions 
to the outpatient unit, thereby allowing hospital beds to be relieved, for carrying out volume, costly 
surgical interventions that require a long stay of the patient under the round-the-clock supervision 
of the hospital physician.
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1. Inpatient technologies and techniques can reduce the burden on hospitals. 
2. The development of hospital-replacing forms of medical care is determined, on the one 
hand, by the need of the population for this type of medical services, on the other, by the need 
for rational and efficient use of financial resources and material and technical resources of health 
care, that is, the objective need of the health care system itself acting in real social economic 
environment.
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Abstract
The article dedicated to the problem of the diagnostic value of morphological changes in gastroesophageal reflux disease in 
the biopsy of the distal esophagus in pubertal children of childbearing age. 
Aim of the research is to investigate the diagnostic value of morphological changes in gastroesophageal reflux disease in 
esophageal biopsy material in adolescents sickly with acute respiratory diseases.
Methodology. The objective of the study was achieved through examination of 90 adolescents (10 to 16 years old, average 
age 13.1±3.54 years) kept under observation at the Children’s Clinical Hospital No. 9 of Kyiv and on the basis of the Department of 
Pediatrics No. 1 Center of Primary Health Care No. 4 of the Desnianskyi district of Kyiv. All adolescents belonged to the group of 
sickly with a number of respiratory diseases averaging 6–8 times a year, lasting from 8 to 18 days (on average 12.8±5.41 days). All 
children have undergone endoscopic examination of the esophagus, stomach and duodenum with the esophagus mucosa biopsy using 
the OLYMPUS GIF-P3 flexible fiberscope.
